adults with chronic immune thrombocytopenia (ITP) when certain medicines or surgery to remove the spleen have not worked well enough. Read More

children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove the spleen have not worked well enough.

Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or low platelet count caused by any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1. Close

You are now leaving Nplate.com
Please know that the sponsors of this site are not responsible for content on the site you are about to enter.
This information is intended only for U.S. healthcare professionals. If you are a healthcare professional, click "I Agree" to continue.

Sign Up for Nplate® Navigator

Personalized support and services from a registered nurse

Co-pay and reimbursement resources:
Find co-pay and reimbursement resources* no matter what insurance you have - even if you have none.

Live phone assistance:
Questions? Call Nplate® Navigator to speak with a registered nurse about Nplate®.

Assistance finding an ITP Specialist:
Planning to travel or relocate? Call Nplate® Navigator to get help finding an ITP specialist nearest your location.

*Resources include referrals to independent nonprofit patient assistance programs. Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits' criteria. Amgen has no control over these programs and provides referrals as a courtesy only.

Patients who register with Nplate® Navigator can receive these additional benefits:

Personalized calls from an Nplate® registered nurse
Talk to a registered nurse about topics such as

The information you receive from the Nplate® Navigator is not meant to replace the advice of your healthcare team. Amgen will not provide medical advice regarding your medical condition. The Nplate® Navigator is not intended to diagnose health problems or to take the place of talking with your doctor about your condition, treatment, or medication. Be sure to talk to your doctor at your next visit if you have any questions about adult chronic ITP or Nplate®.

Are you or someone you know currently receiving treatment with Nplate®?
*

YesNo

select one

You are a
*

PatientCaregiver of a patient with ITPFamily member or friend of a patient with ITP

indicate what describes you

By completing this form, you will sign up for more information about Nplate®. If you begin treatment with Nplate®, you can sign up to receive support through Nplate® Navigator.
Sign Up for Nplate® Information

FIRST NAME:
*

enter your first name

LAST NAME:
*

enter your last name

E-MAIL ADDRESS:
*

enter valid email address

PHONE NUMBER (for calls or text messages):
*

enter valid phone number

I give Amgen permission to leave a voice message and/ or send me an SMS/text that refers to the Nplate® Navigator program by name and may include personal health information about my condition or treatment. Standard text message charge may apply.

ADDRESS:
*

enter valid address

ADDRESS 2:

CITY:
*

enter city name

STATE:
*

select your state

ZIP CODE:
*

enter valid zip code

Are you interested in joining the Share Your Journey program? Share Your Journey is a volunteer program for adults with ITP, including adults with chronic ITP using Nplate® who would like to share their real-life experiences. If you select "Yes", you agree to share your personal health information with a Share Your Journey Representative who may contact you regarding your participation in the Share Your Journey program.

YesNo

Privacy Notice and Authorization

*Please read and accept the Privacy Notice

Amgen’s Privacy Pledge to Patients

Amgen respects patients and customers and takes the protection of their privacy very seriously. Amgen pledges the following:

Amgen does not and will not sell or rent your information to marketing companies or mailing list brokers.

Amgen is careful to only collect and/or use personal identifiable information for the
purposes stated in this Authorization and as necessary to provide the services and/or programs the patient or customer chooses to enroll into.

Amgen practices are consistent with federal and state privacy laws, including HIPAA.

Amgen program enrollment is voluntary and always provides patients with
an easy option to cancel participation.

Amgen’s Privacy Notice and Patient Authorization

Uses and Disclosure of Personal Information

I authorize Amgen and its contractors and business partners (“Amgen”) to use and/or disclose
my personal information, including my personal health information, only for the following purposes:

To improve, develop, and evaluate products, services, materials and programs related to my
condition or treatment.

In order for Amgen to provide me with the services and/or programs described above,
Amgen needs to collect and use my personal information, including my personal health information. I
understand that my personal health information may include any information, in electronic or physical
form, in the possession of or derived from a health care provider, health care plan, pharmacy,
pharmaceutical company, laboratory and/or their contractor (“Health Care Provider”). This may include
select information from or about my medical history and general health, my health care plan benefits,
payment limits or restrictions covered by my health care plan policy, and/or my adherence to my treatment.

I authorize my Health Care Providers to disclose my personal health information to
Amgen, and between themselves, as necessary, but only for the purposes stated above in this Authorization.
I understand that certain of my Health Care Providers (such as pharmacies and specialty pharmacies) may
receive remuneration from Amgen in exchange for disclosing my personal health information and/or for using
my information to contact me with communications about Amgen products which have been prescribed to me (for ex. adherence programs) and other patient support services.

Expiration, Right to Obtain a Copy and Right to Cancel

I understand that by signing this form, I authorize my Health Care Providers or others who
might hold my health information to only release it to Amgen employees, as well as to its contractors and
business partners, who are performing the services set forth in this Authorization. I also understand I am
authorizing my personal information, including my personal health information, to be used for the purposes described above. I understand and agree that by signing below, I am authorizing those who rely on this Authorization to release my personal health information for the earlier of five (5) years or until my participation in the program ends through my cancellation, unless a shorter time period is required by state law.

I understand that I can obtain a copy of this Authorization or cancel this Authorization at any time by calling Amgen at 1-844-826-7512 or by writing to Amgen P.O. Box 681308 Indianapolis, IN 46268. If I cancel my consent, I will no longer qualify for the services described. I also understand that if a Health Care Provider is disclosing my personal health information to Amgen on an authorized on-going basis, my cancellation with Amgen will be effective with respect to any such Health Care Providers as soon as they receive notice of my cancellation.

No Effect on Treatment

I understand I do not have to sign this Authorization and that my enrollment in any of the services and/or programs described above is entirely voluntary. I understand that Amgen, as well as Health Care Providers, cannot require me, as a condition of having access to medications, prescription drugs, treatment or other care, to sign this Authorization. Federal Law (including HIPAA) requires a signed authorization in order for Amgen to collect this information from my Health Care Providers. I understand I cannot participate in the listed services and/or programs without signing this Authorization or an equivalent authorization with my Health Care Providers.

Information Received from Health Care Providers

I understand that once my personal health information has been disclosed to Amgen, federal privacy laws may no longer apply and protect it from further disclosure. Amgen agrees, however, to protect my personal health information by only using and disclosing it as stated in the Authorization or as otherwise allowed or required by law. I understand that Amgen does not and will not sell or rent my information to marketing companies or mailing list brokers.

Authorization to Contact

I understand and consent to Amgen contacting me using the contact information provided in this form to enroll me in, operate, and administer Amgen patient support services and/or programs as described above other than promotional communications by telephone or SMS/text (which I can separately opt-in below). I understand that the operation and administration of certain of these services and/or programs may require that Amgen contact me by telephone or SMS/text.

I am entitled to receive a copy of my authorization.

I choose to be contacted by e-mail, phone, mail, and/or SMS/text for the purposes contained in the Privacy Authorization, including to receive informational and marketing communications from Amgen in the future.

By checking the "I Accept" box, I am electronically signing this form (which has the same legal effect as a handwritten signature) and indicating I am at least 18 years old and authorize Amgen, its contractors, and its business partners to use and disclose my Personal Information for the purposes described above. By clicking “Cancel”, I understand I will discontinue my enrollment into the Nplate® Navigator Program and no further action will be taken.

Please note: If you do not want your Personal Information used for the purposes described above, click the Cancel button to discontinue your registration.

*

I ACCEPT *

required

This is a security feature to enhance your protection. Type the characters you see in the picture below.

IMPORTANT SAFETY INFORMATIONWhat is the most important information I should know about Nplate®?
Nplate® can cause serious side effects, including:

Worsening of a precancerous blood condition to a blood cancer (leukemia):
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or for any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.

Higher risk for blood clots:

You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes.

If you have a chronic liver disease, you may get blood clots in the veins of your liver. This may affect your liver function.

What are the possible side effects of Nplate®?

Nplate® may cause serious side effects. See "What is the most important information I should know about Nplate®?"

The most common side effects of Nplate® in adults include:

headache

joint pain

dizziness

trouble sleeping

muscle tenderness or weakness

pain in arms and legs

stomach (abdomen) pain

shoulder pain

indigestion

tingling or numbness in hands and feet

The most common side effects of Nplate® in children 1 year of age and older include:

inflammation of the passages in the nose and throat

upper respiratory tract infection

itchy, runny, or blocked nose

sore throat and discomfort with swallowing

inflammation of the eye

ear infection

inflammation in the lining of the intestines

inflammation of the sinuses

cough

pain in mouth and throat

upper stomach (abdomen) pain

diarrhea

rash

bleeding beneath the surface of the skin or bruising under the skin

itchy rash

fever

swelling in the limbs/hands/feet

bruising

People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin.” These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.

These are not all the possible side effects of Nplate®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.

If you have any questions about this information, be sure to discuss with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

How will I receive Nplate®? Nplate® is given under the skin (subcutaneous injection) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.

Pregnancy Surveillance Program: Women who become pregnant during Nplate® treatment are encouraged to enroll in Amgen’s Pregnancy Surveillance Program. The purpose of this program is to collect safety information about the health of you and your baby. Contact the program as soon as you become aware of the pregnancy, or ask your healthcare provider to contact the program for you. You or your healthcare provider can get information and enroll in the program by calling 1-800-77-AMGEN (1-800-772-6436)1-800-77-AMGEN (1-800-772-6436).

adults with chronic immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough.

children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove the spleen have not worked well enough.

Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or low platelet count caused by any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.

IMPORTANT SAFETY INFORMATIONWhat is the most important information I should know about Nplate®?
Nplate® can cause serious side effects, including:

Worsening of a precancerous blood condition to a blood cancer (leukemia):
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or for any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.

Higher risk for blood clots:

You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes.

If you have a chronic liver disease, you may get blood clots in the veins of your liver. This may affect your liver function.

What are the possible side effects of Nplate®?

Nplate® may cause serious side effects. See "What is the most important information I should know about Nplate®?"

The most common side effects of Nplate® in adults include:

headache

joint pain

dizziness

trouble sleeping

muscle tenderness or weakness

pain in arms and legs

stomach (abdomen) pain

shoulder pain

indigestion

tingling or numbness in hands and feet

The most common side effects of Nplate® in children 1 year of age and older include:

inflammation of the passages in the nose and throat

upper respiratory tract infection

itchy, runny, or blocked nose

sore throat and discomfort with swallowing

inflammation of the eye

ear infection

inflammation in the lining of the intestines

inflammation of the sinuses

cough

pain in mouth and throat

upper stomach (abdomen) pain

diarrhea

rash

bleeding beneath the surface of the skin or bruising under the skin

itchy rash

fever

swelling in the limbs/hands/feet

bruising

People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin.” These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.

These are not all the possible side effects of Nplate®. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.

If you have any questions about this information, be sure to discuss with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

How will I receive Nplate®? Nplate® is given under the skin (subcutaneous injection) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.

Pregnancy Surveillance Program: Women who become pregnant during Nplate® treatment are encouraged to enroll in Amgen’s Pregnancy Surveillance Program. The purpose of this program is to collect safety information about the health of you and your baby. Contact the program as soon as you become aware of the pregnancy, or ask your healthcare provider to contact the program for you. You or your healthcare provider can get information and enroll in the program by calling 1-800-77-AMGEN (1-800-772-6436)1-800-77-AMGEN (1-800-772-6436).

adults with chronic immune thrombocytopenia (ITP) when certain medicines or surgery to remove your spleen have not worked well enough.

children 1 year of age and older with ITP for at least 6 months when certain medicines or surgery to remove the spleen have not worked well enough.

Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or low platelet count caused by any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.